The administration of cannabis extracts is effective and well-tolerated in patients diagnosed with autism spectrum disorders (ASD), according to a new study published in the journal Scientific Reports and published online by the National Institute of Health.
The aim of the study, which included 188 participants, was to “characterize the epidemiology of ASD patients receiving medical cannabis treatment and to describe its safety and efficacy.” To do this researchers examined the daily administration of high-CBD cannabis oil. which consisted of 30% CBD and 1.5% THC.
Among the patients who used the cannabis oil for at least six months, over 90% reported some level of symptomatic improvement; this included reductions in seizures, rage attacks and restlessness. In addition, roughly a third of reported a reduction in other medications.
The study concludes by stating that “Cannabis as a treatment for autism spectrum disorders patients appears to be well-tolerated, safe and seemingly effective option to relieve symptoms, mainly: seizures, tics, depression, restlessness and rage attacks.” They continue by stating that they believe “that double blind placebo-controlled trials are crucial for a better understanding of the cannabis effect on ASD patients.”
The study is titled Real life experience of medical cannabis treatment in autism: Analysis of safety and efficacy.